Cleveland Clinic leads effort to emulate models for Alzheimer’s and Parkinson’s
$10.6M award to help compare escalation with early highly effective treatment
Two weeks of therapy yields sustained benefits
DeSilva lab pursues mechanisms regulating glutamate in demyelinating diseases
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Preliminary findings may augur risk of long-term brain decline
Studies find altered protein levels associated with inflammation, fibrosis
Study indicates ‘yes’ except for certain targeted agents
Study demonstrates benefits in health status, depression and more
ENRICH trial of an MIS approach aims to find out
Effects specific to affective pain sphere argue for shift in surgical targeting
Advertisement
Advertisement